Plasma fibroblast growth factor 23, parathyroid hormone, 25-hydroxyvitamin D3, and risk of heart failure: a

Romina di Giuseppe1, Brian Buijsse, Frank Hirche

  • 1Department of Epidemiology (R.d.G., B.B., J.W., M.A., H.B., C.W.), German Institute of Human Nutrition Potsdam-Rehbrücke, D-14558 Nuthetal, Germany; Institute of Agricultural and Nutritional Sciences (F.H., G.I.S.), Human Nutrition Group, Martin-Luther-University Halle-Wittenberg, D-06108 Halle, Germany; Department for Clinical Chemistry and Pathobiochemistry (S.W., B.I.), Otto-von-Guericke-University Magdeburg, 39106 Magdeburg, Germany; Institute of Epidemiology and Social Medicine (H.W.H.), Clinical Epidemiology Unit, University of Münster, D-48129 Münster, Germany; Department of Clinical Medicine (J.D.), University of Bergen, N-5020 Bergen Norway; and Institute for Social Medicine, Epidemiology, and Health Economics (C.W.), Charité University Medical Center, 10117 Berlin, Germany.

Insights

Higher levels of fibroblast growth factor 23 (FGF23) are linked to an increased risk of heart failure (HF). The study found no clear association for parathyroid hormone (PTH) or 25-hydroxyvitamin D3 [25(OH)D3] with HF risk.

Area of Science:

  • Cardiology
  • Endocrinology
  • Metabolic Research

Background:

  • Bone mineral metabolism is increasingly recognized for its potential role in the pathogenesis of heart failure (HF).
  • Specific biomarkers such as fibroblast growth factor 23 (FGF23), parathyroid hormone (PTH), and 25-hydroxyvitamin D3 [25(OH)D3] are implicated in mineral metabolism and may influence cardiovascular health.

Purpose of the Study:

  • To investigate the association between plasma levels of FGF23, PTH, and 25(OH)D3 and the incidence of congestive heart failure (HF).
  • To examine these relationships in a population-based cohort of middle-aged men and women.

Main Methods:

  • A prospective case-cohort study was conducted within the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort.
  • The study included 221 incident congestive HF cases and 1228 individuals without HF, with a mean follow-up of 8.2 years.

Main Results:

  • Each doubling of FGF23 was associated with a 29% increased risk of HF (HR, 1.29; 95% CI, 1.07-1.56) after multivariable adjustment.
  • PTH was not significantly related to HF risk (HR per doubling, 1.21; 95% CI, 0.99-1.48), although an interaction with obesity suggested a potential link.
  • No significant association was found between 25(OH)D3 and HF risk (HR per doubling, 1.02; 95% CI, 0.73-1.41).

Conclusions:

  • Epidemiological evidence supports a positive relationship between elevated FGF23 levels and an increased risk of developing heart failure.
  • The role of PTH in HF development requires further investigation, particularly in obese populations.
  • Plasma 25(OH)D3 levels do not appear to be associated with incident HF in this cohort.
Abstract

Related Concept Videos

Roles of Electrolytes: Calcium and Phosphate01:27

Roles of Electrolytes: Calcium and Phosphate

Calcium and phosphate are essential electrolytes in the human body, with calcium being the most abundant mineral. Around 99% of the body's calcium is stored in the skeleton and teeth, forming a crystal lattice of mineral salts in combination with phosphates. Calcium plays crucial roles in various bodily functions such as blood clotting, neurotransmitter release, muscle tone maintenance, and nervous and muscle tissue excitability.
The calcium concentration in blood plasma is primarily...
4.6K
Skeleton and Calcium Homeostasis01:21

Skeleton and Calcium Homeostasis

Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
8.4K
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
765
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
5.1K
The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by...
5.2K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
3.5K